# Source:The Wall Street Journal, URL:https://www.youtube.com/feeds/videos.xml?channel_id=UCK7tptUDHh-RYDsdxO1-5QQ, language:en

## How 23andMe Went From $6B Valuation to Penny Stock | WSJ What Went Wrong
 - [https://www.youtube.com/watch?v=gkxxtP9F6FY](https://www.youtube.com/watch?v=gkxxtP9F6FY)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCK7tptUDHh-RYDsdxO1-5QQ
 - date published: 2024-02-08T15:00:39+00:00

DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests to homes with just a tube of spit. But challenges with its business model and continued data privacy concerns for consumers have brought the company once valued at $6 billion to a valuation of nearly $0, with Nasdaq threatening to delist it. 

WSJ explains what went wrong with Wojcicki’s biotech business. 

0:00 Home DNA testing
0:49 The rise of 23andMe
2:18 The turning point
4:03 23andMe’s fall
5:23 What’s next?

What Went Wrong explores the challenging conditions and decisions that led to a company's downturn.

#23andMe #DNA #WSJ

